[Insulin therapy: as early as possible].
The guidelines of the leading national and international diabetes associations enable the early use of insulin in the treatment of type 2 diabetes, in particular, if HbA1c is markedly increased or a rapid metabolic normalisation is aspired. The early use of insulin, and particularly of long-acting insulin analogues, is effective and safe. A short-term aggressive insulin treatment as first-line therapy of a newly diagnosed type 2 diabetes has the potential to induce a prolonged recovery of beta-cell function and improvement of insulin sensitivity.